Cindy Motz
Stock Analyst at Goldman Sachs
(0.32)
# 4,032
Out of 4,711 analysts
21
Total ratings
17.65%
Success rate
-17.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cindy Motz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MPLN MultiPlan | Maintains: Neutral | $220 → $82 | $6.02 | +1,262.13% | 2 | Nov 16, 2022 | |
| HQY HealthEquity | Upgrades: Neutral | $64 → $77 | $94.95 | -18.90% | 3 | Oct 21, 2022 | |
| ACCD Accolade | Maintains: Buy | $15 → $16 | $3.48 | +359.77% | 5 | Oct 7, 2022 | |
| HCAT Health Catalyst | Maintains: Buy | $29 → $18 | $7.09 | +153.88% | 5 | Aug 10, 2022 | |
| DOCS Doximity | Maintains: Buy | $53 → $46 | $57.83 | -20.46% | 3 | Aug 8, 2022 | |
| TDOC Teladoc Health | Downgrades: Neutral | $55 → $36 | $9.44 | +281.36% | 3 | Jul 28, 2022 |
MultiPlan
Nov 16, 2022
Maintains: Neutral
Price Target: $220 → $82
Current: $6.02
Upside: +1,262.13%
HealthEquity
Oct 21, 2022
Upgrades: Neutral
Price Target: $64 → $77
Current: $94.95
Upside: -18.90%
Accolade
Oct 7, 2022
Maintains: Buy
Price Target: $15 → $16
Current: $3.48
Upside: +359.77%
Health Catalyst
Aug 10, 2022
Maintains: Buy
Price Target: $29 → $18
Current: $7.09
Upside: +153.88%
Doximity
Aug 8, 2022
Maintains: Buy
Price Target: $53 → $46
Current: $57.83
Upside: -20.46%
Teladoc Health
Jul 28, 2022
Downgrades: Neutral
Price Target: $55 → $36
Current: $9.44
Upside: +281.36%